Peripheral Blood Gene Expression as a Novel Genomic Biomarker in Complicated Sarcoidosis
Sarcoidosis, a systemic granulomatous syndrome invariably affecting the lung, typically spontaneously remits but in ∼20% of cases progresses with severe lung dysfunction or cardiac and neurologic involvement (complicated sarcoidosis). Unfortunately, current biomarkers fail to distinguish patients wi...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3440319/ |
id |
pubmed-3440319 |
---|---|
recordtype |
oai_dc |
spelling |
pubmed-34403192012-09-14 Peripheral Blood Gene Expression as a Novel Genomic Biomarker in Complicated Sarcoidosis Zhou, Tong Zhang, Wei Sweiss, Nadera J. Chen, Edward S. Moller, David R. Knox, Kenneth S. Ma, Shwu-Fan Wade, Michael S. Noth, Imre Machado, Roberto F. Garcia, Joe G. N. Research Article Sarcoidosis, a systemic granulomatous syndrome invariably affecting the lung, typically spontaneously remits but in ∼20% of cases progresses with severe lung dysfunction or cardiac and neurologic involvement (complicated sarcoidosis). Unfortunately, current biomarkers fail to distinguish patients with remitting (uncomplicated) sarcoidosis from other fibrotic lung disorders, and fail to identify individuals at risk for complicated sarcoidosis. We utilized genome-wide peripheral blood gene expression analysis to identify a 20-gene sarcoidosis biomarker signature distinguishing sarcoidosis (n = 39) from healthy controls (n = 35, 86% classification accuracy) and which served as a molecular signature for complicated sarcoidosis (n = 17). As aberrancies in T cell receptor (TCR) signaling, JAK-STAT (JS) signaling, and cytokine-cytokine receptor (CCR) signaling are implicated in sarcoidosis pathogenesis, a 31-gene signature comprised of T cell signaling pathway genes associated with sarcoidosis (TCR/JS/CCR) was compared to the unbiased 20-gene biomarker signature but proved inferior in prediction accuracy in distinguishing complicated from uncomplicated sarcoidosis. Additional validation strategies included significant association of single nucleotide polymorphisms (SNPs) in signature genes with sarcoidosis susceptibility and severity (unbiased signature genes - CX3CR1, FKBP1A, NOG, RBM12B, SENS3, TSHZ2; T cell/JAK-STAT pathway genes such as AKT3, CBLB, DLG1, IFNG, IL2RA, IL7R, ITK, JUN, MALT1, NFATC2, PLCG1, SPRED1). In summary, this validated peripheral blood molecular gene signature appears to be a valuable biomarker in identifying cases with sarcoidoisis and predicting risk for complicated sarcoidosis. Public Library of Science 2012-09-12 /pmc/articles/PMC3440319/ /pubmed/22984568 http://dx.doi.org/10.1371/journal.pone.0044818 Text en © 2012 Zhou et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
repository_type |
Open Access Journal |
institution_category |
Foreign Institution |
institution |
US National Center for Biotechnology Information |
building |
NCBI PubMed |
collection |
Online Access |
language |
English |
format |
Online |
author |
Zhou, Tong Zhang, Wei Sweiss, Nadera J. Chen, Edward S. Moller, David R. Knox, Kenneth S. Ma, Shwu-Fan Wade, Michael S. Noth, Imre Machado, Roberto F. Garcia, Joe G. N. |
spellingShingle |
Zhou, Tong Zhang, Wei Sweiss, Nadera J. Chen, Edward S. Moller, David R. Knox, Kenneth S. Ma, Shwu-Fan Wade, Michael S. Noth, Imre Machado, Roberto F. Garcia, Joe G. N. Peripheral Blood Gene Expression as a Novel Genomic Biomarker in Complicated Sarcoidosis |
author_facet |
Zhou, Tong Zhang, Wei Sweiss, Nadera J. Chen, Edward S. Moller, David R. Knox, Kenneth S. Ma, Shwu-Fan Wade, Michael S. Noth, Imre Machado, Roberto F. Garcia, Joe G. N. |
author_sort |
Zhou, Tong |
title |
Peripheral Blood Gene Expression as a Novel Genomic Biomarker in Complicated Sarcoidosis |
title_short |
Peripheral Blood Gene Expression as a Novel Genomic Biomarker in Complicated Sarcoidosis |
title_full |
Peripheral Blood Gene Expression as a Novel Genomic Biomarker in Complicated Sarcoidosis |
title_fullStr |
Peripheral Blood Gene Expression as a Novel Genomic Biomarker in Complicated Sarcoidosis |
title_full_unstemmed |
Peripheral Blood Gene Expression as a Novel Genomic Biomarker in Complicated Sarcoidosis |
title_sort |
peripheral blood gene expression as a novel genomic biomarker in complicated sarcoidosis |
description |
Sarcoidosis, a systemic granulomatous syndrome invariably affecting the lung, typically spontaneously remits but in ∼20% of cases progresses with severe lung dysfunction or cardiac and neurologic involvement (complicated sarcoidosis). Unfortunately, current biomarkers fail to distinguish patients with remitting (uncomplicated) sarcoidosis from other fibrotic lung disorders, and fail to identify individuals at risk for complicated sarcoidosis. We utilized genome-wide peripheral blood gene expression analysis to identify a 20-gene sarcoidosis biomarker signature distinguishing sarcoidosis (n = 39) from healthy controls (n = 35, 86% classification accuracy) and which served as a molecular signature for complicated sarcoidosis (n = 17). As aberrancies in T cell receptor (TCR) signaling, JAK-STAT (JS) signaling, and cytokine-cytokine receptor (CCR) signaling are implicated in sarcoidosis pathogenesis, a 31-gene signature comprised of T cell signaling pathway genes associated with sarcoidosis (TCR/JS/CCR) was compared to the unbiased 20-gene biomarker signature but proved inferior in prediction accuracy in distinguishing complicated from uncomplicated sarcoidosis. Additional validation strategies included significant association of single nucleotide polymorphisms (SNPs) in signature genes with sarcoidosis susceptibility and severity (unbiased signature genes - CX3CR1, FKBP1A, NOG, RBM12B, SENS3, TSHZ2; T cell/JAK-STAT pathway genes such as AKT3, CBLB, DLG1, IFNG, IL2RA, IL7R, ITK, JUN, MALT1, NFATC2, PLCG1, SPRED1). In summary, this validated peripheral blood molecular gene signature appears to be a valuable biomarker in identifying cases with sarcoidoisis and predicting risk for complicated sarcoidosis. |
publisher |
Public Library of Science |
publishDate |
2012 |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3440319/ |
_version_ |
1611908076335529984 |